Our Company

Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.

Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects such as the “Making More Health” initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees’ different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does. 

More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.

Vision

A successful and independent Corporation 

Value through Innovation is the central concept of our corporate vision. Together with the corporate culture concept “Lead & Learn”, this is the driver of the corporate culture.

History

The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer (1861-1939) in Ingelheim am Rhein. From its beginnings in 1885 when it employed just 28 people in Nieder-Ingelheim, the company has since become a global enterprise.

As part of research and development activities for innovative drugs, the company focuses primarily on the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology.

Diversity & Inclusion

We at Boehringer Ingelheim value and respect the differences of our people and nurture a diverse, collaborative and open company culture. For us ‘Diversity is the mix. Inclusion is making the mix work’. Therefore, we foster an inclusive environment which allows diversity to flourish. Valuing the diversity of thought and creating an inclusive culture is not only the right thing to do for our people, it’s the smart thing to do for our business.

Transparency 

At Boehringer Ingelheim, we prioritize the establishment and maintenance of public trust. Transparency is therefore a key pillar of our corporate culture, as well as a vital principle in healthcare compliance.

Sustainability

In all our endeavours we safeguard our employees, facilities and the environment from harmful influences, conserve natural resources and promote environmental awareness.

Corporate Citizenship

We seek to foster economic and social well-being in the countries and communities in which we do business. Corporate citizenship is an integral part of our corporate culture.

Our activities, therefore, emanate from our operating units in the countries and embrace patients, neighbouring communities and society at large.